Investor Moves
| Name | Value | Action | Change | Price | Current Price |
|---|---|---|---|---|---|
Jim SimonsRenaissance Technologies $-19.6K ExitQ1 2026 $20k -- $0.3326 | |||||
Ken GriffinCitadel Advisors $26k50.6k shares TrimQ1 2026 $8.6k $0.5113 $0.3326 | |||||
News
prnewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)prnewswire.comMay 22
prnewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)prnewswire.comMay 18
globenewswire.comCuranex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submissionglobenewswire.comMay 14
prnewswire.comWolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Curanex Pharmaceuticals Inc. (NASDAQ: CURX)prnewswire.comMay 12
globenewswire.comCURX Investors Have Opportunity to Join Curanex Pharmaceuticals Inc Fraud Investigation with the Schall Law Firmglobenewswire.comApr 30